Literature DB >> 21327630

Rho-kinase in development and heart failure: insights from genetic models.

Jianjian Shi1, Lumin Zhang, Lei Wei.   

Abstract

Rho-kinase (ROCK) belongs to the AGC (protein kinase A/protein kinase G/protein kinase C, PKA/PKG/PKC) family of serine/threonine kinases and is a major downstream effector of small GTPase RhoA. Rho-kinase is involved in a wide range of fundamental cellular functions such as contraction, adhesion, migration, and proliferation. Two ROCK isoforms, ROCK1 and ROCK2, are assumed to be functionally redundant, based largely on the major common activators, the high degree of homology within the kinase domain, and studies from overexpression with kinase constructs and chemical inhibitors (e.g., Y27632 and fasudil), which inhibit both ROCK1 and ROCK2. Gene targeting and RNA interference approaches allow further dissection of distinct cellular, physiologic, and pathophysiologic functions of the two ROCK isoforms. This review focuses on the current understanding of ROCK isoform biology, with a particular emphasis on their functions in mouse development and the pathogenesis of heart failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21327630      PMCID: PMC3085170          DOI: 10.1007/s00246-011-9920-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  82 in total

1.  Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heart.

Authors:  Ravi Rajashree; Bradford C Blunt; Polly A Hofmann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-05-20       Impact factor: 4.733

2.  Fibronectin matrix assembly requires distinct contributions from Rho kinases I and -II.

Authors:  Atsuko Yoneda; Dmitriy Ushakov; Hinke A B Multhaupt; John R Couchman
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

3.  ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo.

Authors:  Dean Thumkeo; Yoshihiko Shimizu; Satoko Sakamoto; Shuichi Yamada; Shuh Narumiya
Journal:  Genes Cells       Date:  2005-08       Impact factor: 1.891

4.  RhoE function is regulated by ROCK I-mediated phosphorylation.

Authors:  Kirsi Riento; Nick Totty; Priam Villalonga; Ritu Garg; Rosa Guasch; Anne J Ridley
Journal:  EMBO J       Date:  2005-03-03       Impact factor: 11.598

5.  Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis.

Authors:  Jiang Chang; Min Xie; Viraj R Shah; Michael D Schneider; Mark L Entman; Lei Wei; Robert J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

6.  Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice.

Authors:  Ping Fu; Fang Liu; Spencer Su; Wansheng Wang; Xiao R Huang; Mark L Entman; Robert J Schwartz; Lei Wei; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2006-09-27       Impact factor: 10.121

7.  Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis.

Authors:  Ying-Min Zhang; Jacqueline Bo; George E Taffet; Jiang Chang; Jianjian Shi; Anilkumar K Reddy; Lloyd H Michael; Michael D Schneider; Mark L Entman; Robert J Schwartz; Lei Wei
Journal:  FASEB J       Date:  2006-05       Impact factor: 5.191

8.  Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice.

Authors:  Yoshiyuki Rikitake; Naotsugu Oyama; Chao-Yung C Wang; Kensuke Noma; Minoru Satoh; Hyung-Hwan Kim; James K Liao
Journal:  Circulation       Date:  2005-10-31       Impact factor: 29.690

9.  RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis.

Authors:  Dominic P Del Re; Shigeki Miyamoto; Joan Heller Brown
Journal:  J Biol Chem       Date:  2007-01-18       Impact factor: 5.157

10.  The Rho kinases I and II regulate different aspects of myosin II activity.

Authors:  Atsuko Yoneda; Hinke A B Multhaupt; John R Couchman
Journal:  J Cell Biol       Date:  2005-07-25       Impact factor: 10.539

View more
  25 in total

Review 1.  Rho-kinase: regulation, (dys)function, and inhibition.

Authors:  Ehsan Amin; Badri Nath Dubey; Si-Cai Zhang; Lothar Gremer; Radovan Dvorsky; Jens M Moll; Mohamed S Taha; Luitgard Nagel-Steger; Roland P Piekorz; Avril V Somlyo; Mohammad R Ahmadian
Journal:  Biol Chem       Date:  2013-11       Impact factor: 3.915

Review 2.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

3.  Amelioration of albuminuria in ROCK1 knockout mice with streptozotocin-induced diabetic kidney disease.

Authors:  Li Zhou; Fei Liu; Xiao R Huang; Fang Liu; Haiyong Chen; Arther C K Chung; Jianjian Shi; Lei Wei; Hui Y Lan; Ping Fu
Journal:  Am J Nephrol       Date:  2011-10-04       Impact factor: 3.754

4.  A collapsin response mediator protein 2 isoform controls myosin II-mediated cell migration and matrix assembly by trapping ROCK II.

Authors:  Atsuko Yoneda; Marie Morgan-Fisher; Robin Wait; John R Couchman; Ulla M Wewer
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

5.  Disruption of both ROCK1 and ROCK2 genes in cardiomyocytes promotes autophagy and reduces cardiac fibrosis during aging.

Authors:  Jianjian Shi; Michelle Surma; Yang Yang; Lei Wei
Journal:  FASEB J       Date:  2019-03-08       Impact factor: 5.191

Review 6.  Rho kinase as a therapeutic target in cardiovascular disease.

Authors:  Michelle Surma; Lei Wei; Jianjian Shi
Journal:  Future Cardiol       Date:  2011-09

7.  RhoA protects the mouse heart against ischemia/reperfusion injury.

Authors:  Sunny Yang Xiang; Davy Vanhoutte; Dominic P Del Re; Nicole H Purcell; Haiyun Ling; Indroneal Banerjee; Julie Bossuyt; Richard A Lang; Yi Zheng; Scot J Matkovich; Shigeki Miyamoto; Jeffery D Molkentin; Gerald W Dorn; Joan Heller Brown
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

8.  Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.

Authors:  Claudia Mera; Iván Godoy; Renato Ramírez; Jackeline Moya; María Paz Ocaranza; Jorge E Jalil
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-10-21

Review 9.  Signaling effectors underlying pathologic growth and remodeling of the heart.

Authors:  Jop H van Berlo; Marjorie Maillet; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

10.  Hypoxic induction of T-type Ca(2+) channels in rat cardiac myocytes: role of HIF-1α and RhoA/ROCK signalling.

Authors:  P González-Rodríguez; D Falcón; M J Castro; J Ureña; J López-Barneo; A Castellano
Journal:  J Physiol       Date:  2015-10-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.